From: Stem cells and beta cell replacement therapy: a prospective health technology assessment study
Production setting | Factors | Full dose costsa | ||||
---|---|---|---|---|---|---|
Cell culture | Supply | Cost of goods downstream | Regulatory | Mean | Lower range | Upper range |
Adherent | 50 | 3 | 1.2 | $170,795 | $76,680 | $302,040 |
Adherent | 500 | 3 | 1.2 | $138,906 | $52,920 | $265,680 |
Suspension | 50 | 3 | 1.2 | $119,495 | $60,840 | $197,640 |
Suspension | 500 | 3 | 1.2 | $99,126 | $37,080 | $191,160 |